Is phototherapy indicated for a 14‑day‑old infant with a total serum bilirubin of approximately 280 µmol/L who was discharged after being told the level was below the treatment threshold?

A 14-day-old infant with TSB of 280 µmol/L (~16.4 mg/dL) who was told the level was below the phototherapy threshold requires immediate re-evaluation with a new TSB measurement and likely needs phototherapy.

This infant should not have been discharged without clear follow-up instructions, and you should obtain an urgent TSB measurement now to determine if phototherapy is indicated.

Clinical Assessment

The critical issue here is that phototherapy thresholds are age-specific and hour-specific, not just based on absolute bilirubin values 1. At 14 days of age (336 hours), the phototherapy threshold varies based on:

• Gestational age (≥38 weeks vs <38 weeks)
• Presence of neurotoxicity risk factors (G6PD deficiency, hemolysis, sepsis, acidosis, albumin <3.0 g/dL)

For a term infant ≥38 weeks without risk factors at 14 days, the phototherapy threshold is typically around 15-17 mg/dL. For infants <38 weeks or with risk factors, thresholds are lower 1.

Immediate Actions Required

1. Obtain a new TSB measurement immediately - do not rely on transcutaneous bilirubin (TcB) for treatment decisions 1. The previous measurement may have been:

• Incorrectly interpreted
• Plotted on the wrong curve
• Taken when the infant was younger with a different threshold

2. Plot the current TSB on the appropriate hour-specific phototherapy nomogram based on:

• Exact gestational age at birth
• Current postnatal age in hours
• Presence or absence of neurotoxicity risk factors

3. Evaluate for underlying causes of prolonged jaundice at 14 days 1:

• Check for adequate feeding and weight gain
• Assess for signs of hemolysis (rapid bilirubin rise >0.2 mg/dL/hour)
• Consider G6PD deficiency testing
• Evaluate for other pathologic causes (hypothyroidism, biliary atresia if conjugated fraction elevated)

Treatment Decision Algorithm

If current TSB is at or above the phototherapy threshold:

• Initiate intensive phototherapy immediately 1
• Home phototherapy is an option if the infant meets specific criteria: clinically well, feeding adequately, reliable family, and appropriate follow-up can be arranged 1
• Measure TSB again within 4-6 hours to verify efficacy 1

If current TSB is below threshold but within 3 mg/dL (51 µmol/L):

• Close follow-up with repeat TSB within 12-24 hours 1
• Research shows infants discharged ≤5.5 mg/dL below threshold have 7.9% readmission rate versus 1.2% for those >5.5 mg/dL below 2

If current TSB is >3 mg/dL below threshold:

• Follow-up within 1-2 days with clinical assessment
• Consider repeat bilirubin if jaundice appears to be worsening clinically

Critical Pitfalls to Avoid

Do not assume the discharge assessment was correct. At 14 days of age with a TSB of 280 µmol/L, this infant is at significant risk and requires verification. Common errors include:

• Misplotting on nomograms - using the wrong gestational age category or failing to account for risk factors
• Using TcB for treatment decisions - TcB is only for screening; all treatment decisions must be based on TSB 1
• Failing to recognize risk factors - infants with G6PD deficiency, positive DAT, or gestational age <38 weeks have lower thresholds 1

Rebound hyperbilirubinemia is a real concern in infants who previously received phototherapy, especially if they were:

• Treated before 48 hours of age
• <38 weeks gestation
• Have positive DAT or suspected hemolysis 1

These infants require TSB measurement 8-12 hours after phototherapy discontinuation 1.

Risk Stratification

This 14-day-old infant with persistent jaundice warrants heightened concern because:

• Prolonged jaundice beyond 2 weeks suggests possible pathologic causes
• Asian and Hispanic ethnicity increases risk (if applicable) 2
• Exclusive breastfeeding is associated with higher readmission rates (3.3% vs 1.4% for formula) 2

Bottom Line

Obtain an urgent TSB measurement now and compare it to the age-specific, risk-adjusted phototherapy threshold. The margin of safety matters - infants discharged close to threshold have substantially higher readmission rates 2, 3. If phototherapy is needed, home phototherapy successfully treats 98% of cases when comprehensive support is provided 4, but hospital admission may be necessary if the TSB is rising rapidly or approaching exchange transfusion levels (typically >25 mg/dL in term infants) 1.